Skip to main content
. Author manuscript; available in PMC: 2022 Apr 25.
Published in final edited form as: Methods Mol Biol. 2021;2245:195–213. doi: 10.1007/978-1-0716-1119-7_14

Fig. 4.

Fig. 4

Pharmacologic activation of AMPK significantly improved SIRT3 activity in OA chondrocytes. Cultured primary human knee OA chondrocytes were treated with AMPK pharmacological activator A-769662 (0.125 mM) for 2 h, and the SIRT3 activity was measured. (This figure is reproduced from ref. 13 with permission from Elsevier)